Effects of Nucleotide-Rich Kluyveromyces fragilis and Saccharomyces cerevisiae Yeast Extracts on Cognitive Function in Older Adults with Mild Cognitive Impairment: A Randomized Placebo-Controlled Trial
Nutrients · 10.06.2026 · 18 (12) · 1869
DOI: 10.3390/nu18121869 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 10.06.2026. Verfasst von Hammad Ullah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Abbottabad 22060, Pakistan. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Kluyveromyces, Cognitive Dysfunction, Cognition. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background/Objectives: Mild cognitive impairment (MCI) may precede dementia, and safe nutritional strategies able to support cognitive function are of clinical interest. Dietary nucleotides may contribute to membrane phospholipid synthesis, synaptic function, and neuroprotective pathways; however, clinical evidence in older adults with MCI remains limited. This randomized placebo-controlled trial evaluated the efficacy and tolerability of nucleotide-rich yeast extracts from Kluyveromyces fragilis and Saccharomyces cerevisiae.
Methods
Seventy-two participants (mean age 73.5 ± 7.7 years; range 60–85) were randomly assigned (1:1:1) to receive K. fragilis extract, S. cerevisiae extract, or placebo once daily for 180 days. Cognitive outcomes were assessed using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) at baseline (T0), 90 days (T1), and 180 days (T2); quality of life was assessed using the SF-12 questionnaire at T0 and T2. Treatment effects were analyzed using linear mixed-effects models adjusted for age and sex.
Results
After 180 days, MoCA scores increased by 4.42 points in the K. fragilis group and 3.92 points in the S. cerevisiae group, compared with 0.58 points in the placebo group (time × treatment p < 0.001; T0–T2 within-group p < 0.001 for both active groups and p = 0.14 for placebo). MMSE scores increased by 1.62 and 3.11 points in the K. fragilis and S. cerevisiae groups, respectively, compared with 0.25 points in the placebo group (time × treatment p < 0.001; T0–T2 within-group p < 0.001 for both active groups and p = 0.57 for placebo). The SF-12 mental component score increased by 7.50 and 9.16 points in the two active groups, respectively (time × treatment p = 0.022; T0–T2 p = 0.0013 and p < 0.001, respectively), while physical quality-of-life scores did not change significantly (PCS time × treatment p = 0.11). No adverse events were reported.
Conclusions
Nucleotide-rich K. fragilis and S. cerevisiae yeast extracts were well tolerated and were associated with improved cognitive scores over six months in older adults with MCI. Larger multicenter trials are needed to confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Abbottabad 22060, Pakistan.
- School of Medicine, University of Milano-Bicocca, 20126 Milan, Italy.
- Department of Pharmacy, University of Napoli Federico II, 80131 Naples, Italy.
- Anaesthesia and Resuscitation A. U. O. Luigi Vanvitelli, 80138 Naples, Italy.
- Applied Statistic Unit, Department of Earth and Environmental Sciences, University of Pavia, 27100 Pavia, Italy.
- Comegen S.C.S., Società Cooperativa Sociale, 80125 Naples, Italy.
ORCID-Profile: Hammad Ullah, Maria Vittoria Morone, Alessandra Baldi, Roberto Sacchi, Gaetano Piccinocchi, Alessandro Di Minno, Maria Daglia
Zitieren
APA
Ullah, H., Cordara, M., Morone, M. V., Piccinocchi, R., De Lellis, L. F., Cerqua, A., Baldi, A., Sacchi, R., Piccinocchi, G., Di Minno, A., Spadarella, G., & Daglia, M. (2026). Effects of Nucleotide-Rich Kluyveromyces fragilis and Saccharomyces cerevisiae Yeast Extracts on Cognitive Function in Older Adults with Mild Cognitive Impairment: A Randomized Placebo-Controlled Trial. Nutrients, 18(12), 1869. https://doi.org/10.3390/nu18121869
Vancouver
Ullah H, Cordara M, Morone MV, Piccinocchi R, De Lellis LF, Cerqua A, et al. Effects of Nucleotide-Rich Kluyveromyces fragilis and Saccharomyces cerevisiae Yeast Extracts on Cognitive Function in Older Adults with Mild Cognitive Impairment: A Randomized Placebo-Controlled Trial. Nutrients. 2026;18(12):1869. doi:10.3390/nu18121869
BibTeX
@article{Ullah2026,
author = {Ullah, Hammad and Cordara, Marcello and Morone, Maria Vittoria and Piccinocchi, Roberto and De Lellis, Lorenza Francesca and Cerqua, Angela and Baldi, Alessandra and Sacchi, Roberto and Piccinocchi, Gaetano and Di Minno, Alessandro and Spadarella, Gaia and Daglia, Maria},
title = {Effects of Nucleotide-Rich Kluyveromyces fragilis and Saccharomyces cerevisiae Yeast Extracts on Cognitive Function in Older Adults with Mild Cognitive Impairment: A Randomized Placebo-Controlled Trial},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {12},
pages = {1869},
doi = {10.3390/nu18121869}
}
EUVIMED